Inception Sciences

Inception Sciences, founded in 2011, is a small-molecule pharmaceutical incubator. Their focus is on creating high-value therapies with transformative potential to address diseases and conditions with unmet needs. By collaborating with academic experts, Inception Sciences is translating biological insights into highly targeted novel drugs. Their team has an excellent track record in drug discovery, playing a key role in discovering clinical-stage compounds for treating fibrosis, asthma, and COPD at Amira Pharmaceuticals, as well as in the discovery of several high-profile drugs at Merck.